KSD-101 Therapy for EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial

NCT06097793 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

BIOLOGICAL: KSD-101

Sponsor

Kousai Bio Co., Ltd.